Related Experiment Videos
Expression profiling of microdissected pancreatic adenocarcinomas.
Tatjana Crnogorac-Jurcevic1, Evangelos Efthimiou, Torsten Nielsen
1Cancer Research UK Molecular Oncology Unit, Imperial College School of Medicine at Hammersmith Campus, London, UK.
Oncogene
|June 27, 2002
Summary
This study identifies novel genes involved in pancreatic cancer progression. Researchers discovered new overexpressed and downregulated genes, offering potential targets for future pancreatic cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Pancreatic ductal adenocarcinoma features few cancer cells within a dense stroma.
- Accurate molecular profiling requires isolating pure cell populations.
Purpose of the Study:
- To identify novel genes dysregulated in pancreatic ductal adenocarcinoma.
- To compare gene expression profiles of normal and neoplastic pancreatic ductal cells.
Main Methods:
- Laser capture microdissection to isolate pure cell populations.
- Human cDNA arrays for comparative gene expression analysis.
- Quantitative real-time RT-PCR and immunohistochemistry for validation.
Main Results:
- Identified dysregulated genes in cell cycle, growth, invasion, signaling, and development.
- Confirmed overexpression of ABL2, Notch4, and SOD1.
- Confirmed downregulation of the DNA repair gene XRCC1.
Conclusions:
- Gene expression profiling of pure pancreatic cell populations is informative for understanding pancreatic cancer pathology.
- Newly identified genes like ABL2, Notch4, SOD1, and XRCC1 represent potential diagnostic or therapeutic targets.